of Health Economics
Anna Vassall is a health economist with over twenty five years of experience in economic analysis in low and middle income countries. Her first degree is in economics. She then worked in the NHS supporting funding/contracting. She then took an MSc in Health Planning and Financing at the LSHTM, thereafter working for DFID as a health economist in the UK and Pakistan. This was followed by a period at Royal Tropical Institute (KIT) Amsterdam working on health planning and financing, aid effectiveness and the cost-effectiveness of tuberculosis and reproductive health in a wide range of low and middle income countries. Thereafter she directed and provided economic support to European Community and World Bank funded health sector reform and development projects in Yemen, East Timor, Syria and Sudan. Her PhD is in economic evaluation from the University of Amsterdam.
Anna leads the economic evaluation and priority setting group in the Department of Global Health at LSHTM and as part of the Centre for Health Economics in London (CHIL). She has worked at LSHTM since 2010 specialising on the economics of HIV, sexual and reproductive health, gender based violence prevention and tuberculosis (TB). She has led a wide range of economic analyses on HIV prevention for key populations (Avahan programme), the integration and organisation of HIV care and treatment services (Integra project), and new diagnostics for TB (Xpert MTB/RIF). She has an interest in methods to incorporate health systems constraints and a societal perspective into economic evaluation and priority setting. She is the module organiser for LSHTM's distance learnign course in economic evaluation.
She is a founding member of the TB-MAC modelling consortium and sits on the Strategic and Technical Advisory Group for the WHO's Global TB Programme (STAG-TB) and Task Force on Catastrophic Cost Measurement for TB. She is a lead investigator of the Global Health Costing Consortium; a Bill and Melinda Gates funded project to estimate and analyse HIV, TB and other health service costs globally. She is currently leading the first large multi-country study on the costs and cost-effectiveness of the prevention of violence against women and girls, funded by the Department of International Development (DfiID). She also holds the Joep Lange Chair at the Amsterdam Institute for Global Health, University of Amsterdam.
Her current research interest is the public choice, priority setting and economic evaluation for HIV, TB and Sexual Reproductive Health. She has a keen interest in 'real world' evaluation methods and incorporating a broader health systems perspective in economic analysis. She has also published on health services financing, in particular the role of development assistance for health.
Anna is a member of the Social and Mathematical Epidemiology Group, within Global Health and Development.